Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-006271

Options or other derivatives

  • General Counsel/Secretary acquired 699,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Leavitt Chase C. General Counsel/Secretary 2021-03-15 Grant or award · Employee Stock Option (Right to Buy) +699,100 699,100 D: show line 1 in the form
Loading xslF345X03/ownership.xml…